In summary, the present work show that daphnegiravone D markedly suppress the proliferation and survival of hepatoma cells, and induce G0/G1 arrest by reducing the expression of cyclin E1, CDK2 and CDK4 in a p38-dependent manner. This evidence concerns the gene CDK2 and hepatocellular carcinoma.